Your browser doesn't support javascript.
loading
Can ischemia-modified albumin be used as an objective biomarker for renal ischemic damage? An experimental study with Wistar albino rats.
Kocan, H; Citgez, S; Yucetas, U; Yucetas, E; Yazici, M; Amasyali, A S; Unluer, E; Tasci, A I.
Afiliação
  • Kocan H; Department of Urology, Necmi Ayanoglu Silivri State Hospital, Istanbul, Turkey.
  • Citgez S; Department of Urology, Necmi Ayanoglu Silivri State Hospital, Istanbul, Turkey. Electronic address: drsinharib@yahoo.com.
  • Yucetas U; Department of Urology, Istanbul Training and Research Hospital, Istanbul, Turkey.
  • Yucetas E; Department of Biochemistry, Haseki Training and Research Hospital, Istanbul, Turkey.
  • Yazici M; Department of Urology, Istanbul Training and Research Hospital, Istanbul, Turkey.
  • Amasyali AS; Department of Urology, Istanbul Medical Faculty, Istanbul, Turkey.
  • Unluer E; Department of Urology, Istanbul Training and Research Hospital, Istanbul, Turkey.
  • Tasci AI; Department of Urology, Bakirköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
Transplant Proc ; 46(10): 3326-9, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25498045
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Albumina Sérica / Traumatismo por Reperfusão / Nefropatias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Albumina Sérica / Traumatismo por Reperfusão / Nefropatias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article